Which is the best option for myopia control?
Key points
- Standard, single-vision spectacles or contact lenses do not offer any protection against myopia and are not an effective treatment.
- Treatment options for myopia control in children and teenagers include specialized glasses and soft contact lenses, orthokeratology lenses, atropine eye drops, and light therapies. Each treatment works in different ways to slow the worsening of myopia.
- The optimal treatment depends on a variety of factors including the child’s prescription, eye health, lifestyle and preferences, and what is available in your region. Success also depends on consistent wear and healthy visual habits.
In this article:
Myopia often worsens during childhood, which leads to poorer unassisted vision and an increased risk of eye health complications later in life. Fortunately, several treatments can slow myopia progression, and this is known as myopia control.
This article explains the main options for myopia control in children and teenagers — including specialized glasses, soft contact lenses, orthokeratology, atropine eye drops, and light therapies.
Why does my child need myopia control?
Myopia (near-sightedness) causes blurred vision for objects at a distance, but at higher degrees of myopia, even objects at an arm’s length or closer can appear blurry.
In the majority of cases, myopia develops during childhood (8-13 years), and typically worsens throughout the schooling years through to early adulthood, where it stabilizes.
Myopia control describes the use of treatments that aim to slow the worsening of myopia, particularly in children and teenagers as their eyes are still developing. By slowing myopia progression, a child will end up with less myopia once they reach adulthood.
Having less myopia comes with a wealth of benefits, like better quality vision and more stable lens prescriptions. Perhaps the biggest benefit of avoiding high myopia, is having significantly less risk of developing eye diseases such as retinal detachment and macular degeneration.
Glasses for myopia control
Specialized glasses for myopia control have the ability to slow myopia progression and correct vision, at the same time.
Unlike previous approaches like bifocal and progressive lenses, newer designs have shown high potential for treating myopia progression.
There are a variety of effective myopia control lenses for glasses, including:
- Essilor Stellest
- HOYA MiYOSMART
- SightGlass Vision DOT
- Zeiss MyoCare and MyoCare S
Myopia control glasses look and feel like regular glasses, making them a simple and safe option for most children. Many children adapt quickly to wearing these lenses and enjoy clear, comfortable vision at all distances. Glasses are especially suitable for younger children, but active children may prefer to wear contact lenses.
For the best results, children who are prescribed myopia control glasses should wear their glasses full-time (as their main pair of glasses), except when sleeping or showering.
Soft contact lenses for myopia control
Soft contact lenses for myopia control are specially designed to correct vision while also helping to slow the eye growth that causes myopia to worsen in children.
Similar to myopia control glasses, myopia control soft contact lenses work by slightly changing how light is focussed in the eye, which helps to encourage normal eye growth. Different products achieve this in unique and innovative ways, such as dual-focus, concentric power rings, or extended-depth-of-focus optical designs.
There are several effective soft contact lenses for myopia control, including:
- CooperVision MiSight® 1 day
- Johnson & Johnson Abiliti™ 1-day
- Menicon Bloom Day
- VTI NaturalVue® Multifocal 1 day
- Mark’ennovy MYLO
- Seed 1dayPure EDOF
- CooperVision Biofinity® Multifocal (centre-distance only)
Soft contact lenses are a popular choice for older children and teens, because they offer clear vision without the need for glasses, making them convenient for sports and active lifestyles. Many children quickly adapt to wearing contact lenses and find them comfortable and natural, providing both vision correction and effective myopia control in one treatment.
Once children are taught how to handle contact lenses, they are safe and easy to use as long as proper hygiene is followed.
Soft contact lenses for myopia control are worn during waking hours, and wearing time is very important to getting effective results. While the recommended wearing time varies with each product, well-established products recommend a minimum of 10 hours per day, at least 6 days a week.
Orthokeratology
Orthokeratology, often called ortho-k, is a treatment that uses specially designed rigid contact lenses worn overnight to gently reshape the front surface of the eye (the cornea).
While sleeping, the lenses temporarily flatten the cornea so that vision is clear during the day without the need for glasses or daytime contact lenses. In addition to providing clear vision, this reshaping generates a myopia control effect that helps slow down the eye growth responsible for myopia progression.
Ortho-k products that have been designed specifically for myopia control include:
- CooperVision DreamLite® MC
- Paragon CRT®
- Johnson & Johnson Abiliti™ Overnight Therapeutic Lenses
- Menicon Bloom Night
Ortho-k is a popular choice for active children and teens because it provides freedom from glasses or contact lenses during the day. There are significant benefits for water sports and active lifestyles, and since the contact lenses are only worn overnight, there is minimal risk of the lenses getting lost or broken.
Ortho-k lenses are safe and effective for myopia control, with a strong track record in research that dates back many years.
The ortho-k lenses are worn overnight, and if fitted successfully, no lenses for vision correction need to be worn during the day.
Atropine eye drops
When atropine eye drops are used for myopia control, they are prescribed at very low concentrations (0.01%–0.05%).
It is not certain how atropine slows myopia progression, but research suggests that atropine affects how chemical signals are conducted in the retina – the light sensitive layer at the back of the eye.
Atropine can be effective for treating children with worsening myopia, or when glasses or contact lens-based treatments alone aren’t sufficient. Studies have discovered that when atropine is combined with other myopia control treatments, especially ortho-k, the effects of myopia control can be further enhanced.
Atropine eye drops for myopia control are used once a day, usually before bedtime.
As atropine does not correct blurred vision from myopia, children on atropine treatment will still need glasses or contact lenses to see clearly.
Light therapies for myopia control
Repeated low-level red light (RLRL) therapy is a new and promising approach to slowing myopia progression, though it has been used for decades as an alternative treatment for amblyopia (lazy eye).
A child undergoing a RLRL session.
RLRL therapy uses a specialized device to deliver red light from the visible spectrum (650 ± 10 nm) to control eye growth and myopia progression. Aside from its innovative approach, it has gained a lot of interest for being effective at controlling myopia and eye growth.
Current light therapy options include:
- Eyerising Myopia Management Device
RLRL therapy is convenient and easy to use, as it is performed at home under the guidance of an eye care professional. In the case of the Eyerising International RLRL device, the device is used for 180 seconds at a time, twice a day, for 5 days per week.
Like atropine, RLRL therapy does not involve vision-correcting lenses, so it is normally used either in combination with glasses or contact lenses, or as a standalone treatment.
RLRL therapy is safe when used correctly, but possible side effects include temporary afterimages in vision. Children starting RLRL treatment should have their eye health monitored regularly.
If an afterimage lasts longer than 5 minutes after RLRL treatment, the treatment should be stopped and an eye care professional should be notified.
Which myopia control option is best for my child?
The best myopia control treatment is the one that:
- Is effective at controlling myopia
- Can be used consistently
- Fits a child’s individual needs
Based on current research evidence, the top treatments in each category are able to achieve similar levels of effect.
Consistent use is key to getting the most out of myopia control. Glasses and contact lenses are go-to options because they both correct blurred vision and help control myopia progression at the same time. Unlike atropine or light therapies, these treatments don’t require significant changes to daily routine. Wearing the lenses as often as possible leads to the most effective results.
The best option for your child also depends on your child’s capacity, preferences, and lifestyle. For example, younger children may find handling contact lenses more challenging, although they can typically handle them well from age 6–8. Teenagers may find the atropine not as easy to tolerate, as it can cause mild vision-related side effects. Soft contact lenses and ortho-k are great options for children involved in sports and extracurricular activities.
Managing myopia involves more than treatment alone. Just like regular exercise can strengthen the effects of medication for weight control,
The range of treatments available can vary between regions and different practitioners. For personalized advice, talk to your optometrist or eye doctor.
Want to know more about myopia control? Check out our free-to-download patient brochure, which includes advice on healthy vision habits, contact lenses, myopia control options, and why myopia management is important.
References
- Bullimore MA, Lee SS, Schmid KL, et al. IMI-Onset and Progression of Myopia in Young Adults. Invest Ophthalmol Vis Sci. May 2023;64(6):2. [link]
- Gifford KL, Richdale K, Kang P, et al. IMI - Clinical Management Guidelines Report. Invest Ophthalmol Vis Sci. Feb 2019;60(3):M184-M203. [link]
- Tideman JWL, Snabel MC, Tedja MS, et al. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. Dec 2016;134(12):1355-1363. [link]
- Brennan NA, Toubouti YM, Cheng X, et al. Efficacy in myopia control. Prog Retin Eye Res. Jul 2021;83:100923. [link]
- Sun Y, Xu F, Zhang T, et al. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. Sep 2025;10(4):e0124535. [link]
- Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. Jan 2019;126(1):113-124. [link]
- Chia A, Lu QS, Tan DTH. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. Feb 2016;123(2):391-399. [link]
- Tan Q, Ng AL, Cheng GP, et al. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Cont Lens Anterior Eye. Feb 2023;46(1):101723. [link]
- Jiang Y, Zhu Z, Tan X, et al. Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology. May 2022;129(5):509-519. [link]
- Dong J, Zhu Z, Xu H, et al. Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial. Ophthalmology. Feb 2023;130(2):198-204. [link]
- Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. Mar 2020;104(3):363-368. [link]
- Bao J, Huang Y, Li X, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. May 2022;140(5):472-478. [link]
- Laughton D, Hill JS, McParland M, et al. Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS). BMJ Open Ophthalmol. Oct 2024;9(1). [link]
- Chamberlain P, Peixoto-de-Matos SC, Logan NS, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. Aug 2019;96(8):556-567. [link]
- Cheng X, Xu J, Brennan NA. Randomized Trial of Soft Contact Lenses with Novel Ring Focus for Controlling Myopia Progression. Ophthalmol Sci. Mar 2023;3(1):100232. [link]
- Vina J, Sanchis-Gomar F, Martinez-Bello V, et al. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol. Sep 2012;167(1):1-12. [link]